The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term follow up of E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
 
Barbara Burtness
Consulting or Advisory Role - Abbvie; ALX Oncology; Arvinas; Coherus Biosciences; CUE Biopharma; Eisai; Genentech/Roche; IO Biotech; Janssen Oncology; Kura Oncology; Macrogenics; Merck; Merck KGaA; Merus; Mirati Therapeutics; Orphagen Pharmaceuticals; Rakuten Medical; Seagen; Vaccinex
Speakers' Bureau - Clinical Education Alliance; Oncology Education
Research Funding - CUE Biopharma (Inst); Exelixis (Inst); IO Biotech (Inst); Merck; Merck (Inst)
Expert Testimony - Cel-Sci Corporation
 
Yael Flamand
No Relationships to Disclose
 
Harry Quon
Employment - Johns Hopkins Hospital
Leadership - Pistevo Health
Stock and Other Ownership Interests - Oncospace; Pistevo Health
Honoraria - Sanofi/Regeneron
Consulting or Advisory Role - Pinnacle Biologics; Tactile Medical
Research Funding - Toshiba; Vibrent Health
Patents, Royalties, Other Intellectual Property - Filed under Hopkins, we have several patents related to mobile informatics solutions
Other Relationship - EPIC (I)
 
Gregory S. Weinstein
Patents, Royalties, Other Intellectual Property - Olympus
 
Ranee Mehra
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Coherus Biosciences; Janssen Oncology; Merck KGaA
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Merck KGaA
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Joaquin J. Garcia
No Relationships to Disclose
 
Seungwon Kim
No Relationships to Disclose
 
Bert W. O'malley
No Relationships to Disclose
 
Enver Ozer
No Relationships to Disclose
 
Wayne Koch
No Relationships to Disclose
 
Neil D. Gross
Honoraria - American Institute of Continuing Medical Education; OncLive/MJH Life Sciences
Consulting or Advisory Role - Merck; PDS Biotechnology; Regeneron; Replimune
Research Funding - Regeneron
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - Merck
 
Richard Bryan Bell
Consulting or Advisory Role - Bright Peak Therapeutics; EMD Serono; Macrogenics; Merck
Speakers' Bureau - Regeneron
Research Funding - Bristol-Myers Squibb/Celgene (Inst)
 
Mihir R. Patel
Stock and Other Ownership Interests - Vertex
Honoraria - Intuitive Surgical
Research Funding - Naveris
 
Miriam Lango
No Relationships to Disclose
 
Luc Morris
Patents, Royalties, Other Intellectual Property - I am an inventor on IP owned by Memorial Sloan Kettering Cancer Center and licensed to PGDx
 
Russell Smith
No Relationships to Disclose
 
Daniel Karakla
No Relationships to Disclose
 
Jeremy Richmon
Travel, Accommodations, Expenses - Intuitive Surgical
 
Floyd Christopher Holsinger
Stock and Other Ownership Interests - Photonic Medical
Patents, Royalties, Other Intellectual Property - Founder and Scientific Advisor, Surgical Vision Technologies, Inc.
 
Robert L. Ferris
Stock and Other Ownership Interests - Novasenta
Consulting or Advisory Role - Adagene; Adaptimmune; Aduro Biotech; Bicara Therapeutics; Bristol-Myers Squibb; Cantenion; Coherus Biosciences; CureVac; CytoAgents; Eisai Europe; EMD Serono; Eterna Therapeutics; Everest Clinical Research; F. Hoffmann LaRoche; Federation Bio; Genmab; Genocea Biosciences; Hookipa Pharma; Instil Bio; Kowa Research Institute; Lifescience Dynamics; Macrogenics; MeiraGTx; Merck; Merus NV; Mirati Therapeutics; Mirati Therapeutics; Mirror Biologics; Nanobiotix; Novartis; Novasenta; Numab; OncoCyte; Pfizer; PPD; Rakuten Medical; Regeneron; Sanofi; Seagen; SIRPant Immunotherapeutics; VIR Biotechnology; Zymeworks; Zymeworks
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; Novasenta; Tesaro